Both Zepotide and Semaglutide are innovative medications designed for managing type 2 diabetes and encouraging weight loss . However, they operate through slightly different processes . Semaglutide is a GLP-1 receptor area agonist , while Retatrutide acts as a dual GIP and GLP-1 agonist , conceivably offering a more significant impact on combined b